华润双鹤：复方醋酸钠林格注射液获得药品注册证书

Core Viewpoint - China Resources Double Crane has received a drug registration certificate for Sodium Acetate Compound Injection from the National Medical Products Administration, indicating a significant regulatory approval for a product aimed at treating extracellular fluid deficiency and correcting metabolic acidosis [1] Company Summary - The product, Sodium Acetate Compound Injection, is intended for use in replenishing extracellular fluid during conditions of reduced circulating blood volume and correcting metabolic acidosis [1]